CHILD (Child Health and Infection with Low Density) Malaria
Phase 3
- Conditions
- Malaria
- Registration Number
- PACTR202311470737025
- Lead Sponsor
- niversity of California San Francisco
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
1. 6 months to 10 years.
2. Primary residence in the study area during the study period.
3. Agree to come to study clinic for any illness.
4. Agree to avoid medications outside of study, even herbal medication.
Exclusion Criteria
1. Another child from household already randomly selected for recruitment.
2. Not able or does not provide informed consent.
3. Need for emergency intervention.
4. Known history of chronic illness requiring regular specialty care including diabetes mellitus, cancer, or Stage 3 or 4 HIV/AIDS.
5. Contraindications to artemether-lumefantrine including history of allergic reaction, weight under 5 kg.
6. Participation in another active/on-going intervention trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cumulative incidence of all cause sick visits define as the number of sick visits to health facility excluding planned admissions for medical care, elective surgery, and trauma per person-time.
- Secondary Outcome Measures
Name Time Method